Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil 5% topical foam for male androgenetic alopecia in temple and vertex regions
2010-018291-25Phase 2Completed
- Sponsor
- Klinik für Dermatologie, Venerologie und Allergologie
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in androgenetic alopecia (AGA) comparing Minoxidil foam with Placebo foam (2 arms). Primary endpoint: Change in target area non-vellus hair count in temple region. Started Jun 2010; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2010-018291-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018291-25.